ITUB20153652A1 - Microsfere contenenti lattoni macrociclici antielminitici - Google Patents
Microsfere contenenti lattoni macrociclici antielminiticiInfo
- Publication number
- ITUB20153652A1 ITUB20153652A1 ITUB2015A003652A ITUB20153652A ITUB20153652A1 IT UB20153652 A1 ITUB20153652 A1 IT UB20153652A1 IT UB2015A003652 A ITUB2015A003652 A IT UB2015A003652A IT UB20153652 A ITUB20153652 A IT UB20153652A IT UB20153652 A1 ITUB20153652 A1 IT UB20153652A1
- Authority
- IT
- Italy
- Prior art keywords
- lattons
- elminitic
- microspheres containing
- containing macrocyclic
- macrocyclic anti
- Prior art date
Links
- 239000004005 microsphere Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Feed For Specific Animals (AREA)
- Fats And Perfumes (AREA)
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB2015A003652A ITUB20153652A1 (it) | 2015-09-16 | 2015-09-16 | Microsfere contenenti lattoni macrociclici antielminitici |
KR1020247021000A KR20240108529A (ko) | 2015-09-16 | 2016-09-06 | 구충제 마크로시클릭 락톤을 포함하는 미세구 |
SI201630970T SI3349726T1 (sl) | 2015-09-16 | 2016-09-06 | Mikrosfere, ki vsebujejo antihelmintske makrociklične laktone |
AU2016321801A AU2016321801B2 (en) | 2015-09-16 | 2016-09-06 | Microspheres containing anthelmintic macrocyclic lactones |
PCT/EP2016/070921 WO2017045966A1 (en) | 2015-09-16 | 2016-09-06 | Microspheres containing anthelmintic macrocyclic lactones |
US15/735,233 US10603278B2 (en) | 2015-09-16 | 2016-09-06 | Microspheres containing anthelmintic macrocyclic lactones |
JP2017564811A JP6781717B2 (ja) | 2015-09-16 | 2016-09-06 | 駆虫薬の大環状ラクトンを含むミクロスフェア |
HUE16770213A HUE052553T2 (hu) | 2015-09-16 | 2016-09-06 | Anthelmintikus hatású makrociklusos laktonokat tartalmazó mikrogömbök |
CA2989092A CA2989092C (en) | 2015-09-16 | 2016-09-06 | Microspheres containing anthelmintic macrocyclic lactones |
KR1020177035710A KR20180052559A (ko) | 2015-09-16 | 2016-09-06 | 구충제 마크로시클릭 락톤을 포함하는 미세구 |
PL16770213T PL3349726T3 (pl) | 2015-09-16 | 2016-09-06 | Mikrosfery zawierające przeciwrobacze laktony makrocykliczne |
LTEP16770213.3T LT3349726T (lt) | 2015-09-16 | 2016-09-06 | Mikrosferos, turinčios antihelmintinių makrociklinių laktonų |
RS20201395A RS61100B1 (sr) | 2015-09-16 | 2016-09-06 | Mikrosfere koje sadrže antelmintične makrociklične laktone |
PT167702133T PT3349726T (pt) | 2015-09-16 | 2016-09-06 | Microsferas que contêm lactonas macrocíclicas antihelmínticas |
ES16770213T ES2848559T3 (es) | 2015-09-16 | 2016-09-06 | Microesferas que contienen lactonas macrocíclicas antihelmínticas |
DK16770213.3T DK3349726T3 (da) | 2015-09-16 | 2016-09-06 | Mikrosfærer indeholdende antihelmintiske makrocykliske lactoner |
EP16770213.3A EP3349726B1 (en) | 2015-09-16 | 2016-09-06 | Microspheres containing anthelmintic macrocyclic lactones |
HRP20201783TT HRP20201783T1 (hr) | 2015-09-16 | 2020-11-05 | Mikrosfere koje sadrže anthelmintske makrocikličke laktone |
CY20201101059T CY1123554T1 (el) | 2015-09-16 | 2020-11-10 | Μικροσφαιριδια που περιεχουν αντιελμινθικες μακροκυκλικες λακτονες |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB2015A003652A ITUB20153652A1 (it) | 2015-09-16 | 2015-09-16 | Microsfere contenenti lattoni macrociclici antielminitici |
Publications (1)
Publication Number | Publication Date |
---|---|
ITUB20153652A1 true ITUB20153652A1 (it) | 2017-03-16 |
Family
ID=54884228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITUB2015A003652A ITUB20153652A1 (it) | 2015-09-16 | 2015-09-16 | Microsfere contenenti lattoni macrociclici antielminitici |
Country Status (18)
Country | Link |
---|---|
US (1) | US10603278B2 (it) |
EP (1) | EP3349726B1 (it) |
JP (1) | JP6781717B2 (it) |
KR (2) | KR20240108529A (it) |
AU (1) | AU2016321801B2 (it) |
CA (1) | CA2989092C (it) |
CY (1) | CY1123554T1 (it) |
DK (1) | DK3349726T3 (it) |
ES (1) | ES2848559T3 (it) |
HR (1) | HRP20201783T1 (it) |
HU (1) | HUE052553T2 (it) |
IT (1) | ITUB20153652A1 (it) |
LT (1) | LT3349726T (it) |
PL (1) | PL3349726T3 (it) |
PT (1) | PT3349726T (it) |
RS (1) | RS61100B1 (it) |
SI (1) | SI3349726T1 (it) |
WO (1) | WO2017045966A1 (it) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102101969B1 (ko) * | 2017-09-06 | 2020-04-22 | (주)인벤티지랩 | 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법 |
BR112021016432A2 (pt) * | 2019-02-21 | 2021-11-09 | Chromadex Inc | Composição que compreende prills de cera, processo para produzir prills de cera, composição nutricional, alimento, bebida ou suplemento alimentar que compreende prills de cera, e composição que compreende microesferas encapsuladas |
BR112021021649A2 (pt) * | 2019-05-03 | 2021-12-21 | Intervet Int Bv | Composições farmacêuticas injetáveis e usos das mesmas |
WO2024003291A1 (en) | 2022-06-30 | 2024-01-04 | Virbac | Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction |
CN115040487B (zh) * | 2022-07-04 | 2023-04-25 | 湖北工业大学 | 一种几丁质酶响应性伊维菌素微球及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0525307A1 (en) * | 1991-07-23 | 1993-02-03 | American Cyanamid Company | Stable compositions for parenteral administration and their use |
WO1999043304A1 (en) * | 1998-02-25 | 1999-09-02 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
EP1197207A2 (en) * | 2000-10-10 | 2002-04-17 | American Cyanamid Company | Stable compositions for parenteral administration |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE62125B1 (en) | 1986-03-12 | 1994-12-14 | American Cyanamid Co | Macrolide compounds |
ES2058082T3 (es) | 1986-09-12 | 1994-11-01 | American Cyanamid Co | Derivados 23-oxo (ceto) y 23-imino de compuestos ll-f28249. |
FR2663224B1 (fr) * | 1990-06-14 | 1995-01-20 | Applicationes Farmaceuticas Sa | Forme galenique parenterale. |
AU781682B2 (en) | 2000-03-20 | 2005-06-09 | Zoetis Services Llc | Sustained-release compositions for parenteral administration |
UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
AUPR602501A0 (en) | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
PL1820494T3 (pl) * | 2003-06-13 | 2010-07-30 | Skendi Finance Ltd | Mikrocząstki składające się z estradiolu i cholesterolu |
CA2867079A1 (en) | 2012-03-13 | 2013-09-19 | Bayer New Zealand Limited | Long acting compositions |
-
2015
- 2015-09-16 IT ITUB2015A003652A patent/ITUB20153652A1/it unknown
-
2016
- 2016-09-06 DK DK16770213.3T patent/DK3349726T3/da active
- 2016-09-06 KR KR1020247021000A patent/KR20240108529A/ko not_active Application Discontinuation
- 2016-09-06 JP JP2017564811A patent/JP6781717B2/ja active Active
- 2016-09-06 PT PT167702133T patent/PT3349726T/pt unknown
- 2016-09-06 SI SI201630970T patent/SI3349726T1/sl unknown
- 2016-09-06 WO PCT/EP2016/070921 patent/WO2017045966A1/en active Application Filing
- 2016-09-06 KR KR1020177035710A patent/KR20180052559A/ko not_active IP Right Cessation
- 2016-09-06 ES ES16770213T patent/ES2848559T3/es active Active
- 2016-09-06 US US15/735,233 patent/US10603278B2/en active Active
- 2016-09-06 CA CA2989092A patent/CA2989092C/en active Active
- 2016-09-06 PL PL16770213T patent/PL3349726T3/pl unknown
- 2016-09-06 RS RS20201395A patent/RS61100B1/sr unknown
- 2016-09-06 LT LTEP16770213.3T patent/LT3349726T/lt unknown
- 2016-09-06 EP EP16770213.3A patent/EP3349726B1/en active Active
- 2016-09-06 AU AU2016321801A patent/AU2016321801B2/en active Active
- 2016-09-06 HU HUE16770213A patent/HUE052553T2/hu unknown
-
2020
- 2020-11-05 HR HRP20201783TT patent/HRP20201783T1/hr unknown
- 2020-11-10 CY CY20201101059T patent/CY1123554T1/el unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0525307A1 (en) * | 1991-07-23 | 1993-02-03 | American Cyanamid Company | Stable compositions for parenteral administration and their use |
WO1999043304A1 (en) * | 1998-02-25 | 1999-09-02 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
EP1197207A2 (en) * | 2000-10-10 | 2002-04-17 | American Cyanamid Company | Stable compositions for parenteral administration |
Also Published As
Publication number | Publication date |
---|---|
HUE052553T2 (hu) | 2021-05-28 |
AU2016321801A1 (en) | 2018-01-04 |
ES2848559T3 (es) | 2021-08-10 |
HRP20201783T1 (hr) | 2021-01-22 |
AU2016321801B2 (en) | 2021-11-25 |
SI3349726T1 (sl) | 2020-12-31 |
EP3349726A1 (en) | 2018-07-25 |
US20180177730A1 (en) | 2018-06-28 |
JP2018527291A (ja) | 2018-09-20 |
DK3349726T3 (da) | 2020-11-23 |
CA2989092C (en) | 2023-10-03 |
KR20240108529A (ko) | 2024-07-09 |
LT3349726T (lt) | 2021-02-10 |
CY1123554T1 (el) | 2022-03-24 |
US10603278B2 (en) | 2020-03-31 |
PT3349726T (pt) | 2020-11-23 |
EP3349726B1 (en) | 2020-11-04 |
PL3349726T3 (pl) | 2021-04-06 |
WO2017045966A1 (en) | 2017-03-23 |
JP6781717B2 (ja) | 2020-11-04 |
RS61100B1 (sr) | 2020-12-31 |
KR20180052559A (ko) | 2018-05-18 |
CA2989092A1 (en) | 2017-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3283625T3 (da) | Nukleasemedieret genomeditering | |
DK3331869T3 (da) | Muscarinagonister | |
DK3305788T3 (da) | Janus-kinase-hæmmer | |
DK3277719T3 (da) | Polypeptider | |
DK3360890T3 (da) | Genterapi | |
DK3129350T3 (da) | Makrocyklusser | |
DK3331528T3 (da) | Muskarinagonister | |
DK3331529T3 (da) | Muskarinagonister | |
DK3310450T3 (da) | Olie-vand-separator | |
KR20180084915A (ko) | 구조체 | |
DK3270930T3 (da) | Præeklampsi | |
DK3394281T3 (da) | Gærcelle | |
DK3292136T3 (da) | Penicillin-g-acylaser | |
DK3349726T3 (da) | Mikrosfærer indeholdende antihelmintiske makrocykliske lactoner | |
DK3274482T3 (da) | Stenborsknop | |
DK3318308T3 (da) | Badmintonketsjer | |
DE112015005904A5 (de) | Gurtschlossbringer | |
DE112016005599A5 (de) | Strahlungsgrill | |
ES1140083Y (es) | Descompatactador tetrafunción | |
DE102015206660A8 (de) | Plattenaufteilanlage | |
DE112016001124A5 (de) | Spannschutz | |
FI11070U1 (fi) | Kantojyrsin | |
DE102015000551A8 (de) | Rotationszerstäuberturbine | |
DE102015226549B8 (de) | Hybridheizmodul | |
UA32446S (uk) | Правило |